Abstract 804 Genetic Basis of Disease 1 Platform, Monday, 5/3
HPS consists of oculocutaneous albinism, a platelet storage-pool deficiency, and ceroid lipofuscinosis. Patients exhibit congenital nystagmus, iris transillumination, impaired visual acuity, hypopigmentation, and a bleeding diathesis. Some individuals have granulomatous colitis, and a progressive, fatal pulmonary fibrosis develops in the fourth or fifth decade. The disorder is common in northwest Puerto Rico, but occurs throughout the world. HPS-1, a gene on chromosome 10q23 known to cause HPS, codes for a 79.3 kD protein of unknown function. Patients from northwest Puerto Rico are homozygous for a 16-bp duplication in exon 15 of HPS-1. The basic defect in HPS is unknown, but 14 mouse models exist with hypopigmentation and a storage pool deficiency.
We investigated 80 Puerto Rican and non-Puerto Rican HPS patients at the NIH Clinical Center. Patients with the 16-bp duplication were at increased risk for pulmonary fibrosis. Patients from Central Puerto Rico had entirely normal HPS-1 genes and exhibited milder hypopigmentation compared with duplication patients. Their genetic defect is being mapped by linkage analysis. Among our 27 non-Puerto Rican patients, only 5 have mutations in HPS-1; one of these died of pulmonary fibrosis at age 37. Twenty individuals have HPS due to a gene not yet identified, and two brothers have mutations in the beta-3A subunit of adaptor complex-3 (AP-3). This heterotetrameric coat protein facilitates the formation of vesicles from donor membranes. The brothers represent the first humans identified with a mutation in a coat protein involved in vesicle trafficking. The various genes which cause HPS appear to comprise a pathway responsible for the genesis of melanosomes, platelet dense bodies, and lysosomes.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gahl, W., Shotelersuk, V., Brantly, M. et al. Hermansky-Pudlak Syndrome (HPS) as a Genetically Heterogeneous Disease: Clinical, Molecular, and Cell Biological Aspects. Pediatr Res 45, 138 (1999). https://doi.org/10.1203/00006450-199904020-00821
Issue Date:
DOI: https://doi.org/10.1203/00006450-199904020-00821
This article is cited by
-
Interstitial lung disease in children – genetic background and associated phenotypes
Respiratory Research (2005)